Insider Trading & Ownership - Turka Laurence A.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Turka Laurence A.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-01-31
Sale
2023-01-31
9:50 pm
Rubius Therapeutics Inc.RUBYTurka Laurence A.
Chief Scientific Officer
2,593$0.24$62259,140
(Direct)
View
2022-02-01
Sale
2022-02-01
9:18 pm
Rubius Therapeutics Inc.RUBYTurka Laurence A.
Chief Scientific Officer
2,517$6.573$16,544205,483
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-01-29
Exercise
2023-01-31
9:50 pm
N/A
N/A
Rubius Therapeutics Inc.RUBYTurka Laurence A.
Chief Scientific Officer
16,063$059,140
(Direct)
View
2022-01-31
Option Award
2022-02-01
9:18 pm
N/A
2032-01-30
Rubius Therapeutics Inc.RUBYTurka Laurence A.
Chief Scientific Officer
178,250$0205,483
(Direct)
View
2022-01-29
Exercise
2022-02-01
9:18 pm
N/A
N/A
Rubius Therapeutics Inc.RUBYTurka Laurence A.
Chief Scientific Officer
7,438$0205,483
(Direct)
View
2021-01-29
Option Award
2021-02-02
8:27 pm
N/A
2031-01-28
Rubius Therapeutics Inc.RUBYTurka Laurence A.
Chief Scientific Officer
161,000$0161,000
(Direct)
View
2020-01-31
Option Award
2020-02-03
9:48 pm
N/A
2030-01-30
Rubius Therapeutics Inc.RUBYTurka Laurence A.
Chief Scientific Officer
350,000$0350,000
(Direct)
View